SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-18-142660
Filing Date
2018-04-30
Accepted
2018-04-30 15:04:57
Documents
5
Period of Report
2018-06-26
Effectiveness Date
2018-04-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A d543698ddef14a.htm DEF 14A 1176314
2 GRAPHIC g543698g09q82.jpg GRAPHIC 54462
3 GRAPHIC g543698g36i66.jpg GRAPHIC 6692
4 GRAPHIC g543698g66q90.jpg GRAPHIC 97830
5 GRAPHIC g543698pc01.jpg GRAPHIC 4838
  Complete submission text file 0001193125-18-142660.txt   1403701
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-24006 | Film No.: 18788974
SIC: 2834 Pharmaceutical Preparations